Chong Tang

Title: The Innovations of Chong Tang

Introduction

Chong Tang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid technologies. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this scientific domain.

Latest Patents

Chong Tang holds a patent for a "Splint nucleic acid molecule for cyclizing single-stranded nucleic acid molecule and use thereof." This invention provides a splint nucleic acid molecule designed for cyclizing a single-stranded nucleic acid molecule. The splint nucleic acid molecule consists of a 5' terminal fragment and a 3' terminal fragment. The 5' terminal fragment is adapted to form a first complementary region with the 5' terminal of the single-stranded nucleic acid molecule, while the 3' terminal fragment is suited to form a second complementary region with the 3' terminal of the single-stranded nucleic acid molecule. Notably, the lengths of the first and second complementary regions differ, which enhances the functionality of the molecule.

Career Highlights

Chong Tang is associated with BGI Genomics Co., Limited, a leading company in genomics research and biotechnology. His work at BGI has allowed him to collaborate with other experts in the field and contribute to groundbreaking research initiatives.

Collaborations

One of his notable collaborators is Yiqin Tong, with whom he has worked on various projects related to nucleic acid technologies. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.

Conclusion

Chong Tang's contributions to the field of molecular biology through his patent and work at BGI Genomics Co., Limited highlight his role as an influential inventor. His innovative approaches to nucleic acid technologies continue to pave the way for advancements in genomics.